LITHANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lithane, and what generic alternatives are available?
Lithane is a drug marketed by Bayer Pharms and is included in one NDA.
The generic ingredient in LITHANE is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lithane
A generic version of LITHANE was approved as lithium carbonate by HIKMA on January 29th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LITHANE?
- What are the global sales for LITHANE?
- What is Average Wholesale Price for LITHANE?
Summary for LITHANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 133 |
| Clinical Trials: | 4 |
| Patent Applications: | 2,019 |
| DailyMed Link: | LITHANE at DailyMed |
Recent Clinical Trials for LITHANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| William V. Bobo, M.D. | Phase 2 |
| Nova Scotia Health Authority | Phase 3 |
| National Cancer Institute (NCI) | N/A |
US Patents and Regulatory Information for LITHANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Pharms | LITHANE | lithium carbonate | TABLET;ORAL | 018833-001 | Jul 18, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
